Bleeding and Clotting Disorders
Protocol:GENA-99
Condition or Disease: Hemophilia A
Study Type: Observational
Status: Open for enrollment
Study Title: Prospective, multinational, non-interventional post-authorisation study to document the long-term immunogenicity, safety, and efficacy of Human-cl rhFVIII (simoctocog alfa) in patients with haemophilia A treated in routine clinical practice
Principal I investigator: Joseph Lasky III, MD
More Info: //clinicaltrials.gov/ct2/show/NCT02962765